Speciality Medicines IPO Subscribed 2.27 Times on Day 3

Speciality Medicines Limited's initial public offering (IPO) closed its subscription window at 2.27 times overall subscription by 5:04 PM on Day 3 (March 24, 2026). The ₹29.14 crore book-build issue, priced at ₹117–₹124 per share, received bids for 49,87,000 shares against 22,00,000 shares on offer, with total applications reaching 688.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Subscription Status of Speciality Medicines IPO

Here are the subscription details for Speciality Medicines IPO Day 3, as of 5:04 PM:

Key Highlights – Day 3

• Overall subscription reached 2.27 times, surging from Day 2's 0.94 times, driven by a sharp spike in institutional demand on the final day.
• Qualified institutional buyers (ex-anchor) surged to 96.24 times from 1.00 times on Day 2, indicating concentrated institutional interest on the closing day of this speciality pharma SME IPO.
• Non-institutional investors improved to 1.88 times from Day 2's 1.68 times, with bNII at 2.50 times and sNII at 0.64 times.
• Individual investors improved to 0.85 times from Day 2's 0.19 times, though participation remained below full subscription.
• Total applications reached 688 on Day 3.
   

Key Highlights – Day 2

• Overall subscription reached 0.94 times, broadly unchanged from Day 1's 0.84 times.
• Non-institutional investors recorded 1.68 times, with bNII at 2.47 times and sNII at 0.10 times.
• Qualified institutional buyers (ex-anchor) maintained full subscription at 1.00 times, unchanged from Day 1.
• Individual investors improved to 0.19 times from Day 1's 0.07 times.

Key Highlights – Day 1

• Overall subscription reached 0.84 times on Day 1 (March 20, 2026), reflecting strong initial investor interest in this speciality pharma SME IPO.
• Non-institutional investors led opening participation at 1.60 times, with bNII at 2.37 times and sNII at 0.06 times on Day 1.
• Qualified institutional buyers (ex-anchor) achieved full subscription at 1.00 times on the opening day.
• Individual investors showed subdued participation at 0.07 times on Day 1.
   

About Speciality Medicines Limited

Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals across domestic and international markets. The company operates through contract manufacturing for international distribution and direct marketing of sourced speciality pharmaceutical products, covering over 20 states in India and more than 35 countries. As of February 28, 2026, the company had seven products registered overseas and 54 products in the registration process across five countries.